**MicroPort CRM** is a leading medical device company founded in 2017 with a focus on developing and marketing high-quality medical equipment to improve patient lives. The company operates globally across various industries, including Cardiovascular, Orthopedic, Endovascular, Neurovascular, Electrophysiology, Surgical Management, Diabetes Care, and Endocrinal Management. With a broad product line, MicroPort has established itself as a trusted provider, with one device being utilized every 15 seconds in top hospitals worldwide. The company's recent **$150.00M Series C** investment on **26 July 2021** involved a consortium of investors, including **L Squared Capital Partners, Hillhouse Investment, CICC, E Fund Management Co.,LTD., Wanhai Investment, Yongrong Asset, Country Garden Venture Capital,** and **MicroPort (Shanghai)**. MicroPort's headquarters is in **France**.
MicroPort Scientific Corporation is a dynamic player in the health care industry, with a strong focus on leveraging advanced technology to enhance patient care and revolutionize the field. The company's diverse product portfolio and global presence position it as an attractive investment opportunity for venture capital firms looking to tap into the expanding medical equipment market.
No recent news or press coverage available for MicroPort CRM.